Phibro Animal Health Corporation (FRA:PB8)

Phibro Animal Health Statistics

Total Valuation

FRA:PB8 has a market cap or net worth of EUR 1.42 billion. The enterprise value is 2.03 billion.

Market Cap	1.42B
Enterprise Value	2.03B

Important Dates

The next estimated earnings date is Wednesday, February 4, 2026.

Earnings Date	Feb 4, 2026
Ex-Dividend Date	Nov 26, 2025

Share Statistics

Current Share Class	20.45M
Shares Outstanding	n/a
Shares Change (YoY)	+0.52%
Shares Change (QoQ)	+0.43%
Owned by Insiders (%)	49.63%
Owned by Institutions (%)	50.07%
Float	20.30M

Valuation Ratios

The trailing PE ratio is 24.59 and the forward PE ratio is 14.38.

PE Ratio	24.59
Forward PE	14.38
PS Ratio	1.19
PB Ratio	5.35
P/TBV Ratio	7.68
P/FCF Ratio	48.63
P/OCF Ratio	21.71
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 10.57, with an EV/FCF ratio of 69.31.

EV / Earnings	35.04
EV / Sales	1.68
EV / EBITDA	10.57
EV / EBIT	14.63
EV / FCF	69.31

Financial Position

The company has a current ratio of 3.09, with a Debt / Equity ratio of 2.53.

Current Ratio	3.09
Quick Ratio	1.12
Debt / Equity	2.53
Debt / EBITDA	3.54
Debt / FCF	23.00
Interest Coverage	3.93

Financial Efficiency

Return on equity (ROE) is 23.79% and return on invested capital (ROIC) is 10.74%.

Return on Equity (ROE)	23.79%
Return on Assets (ROA)	8.55%
Return on Invested Capital (ROIC)	10.74%
Return on Capital Employed (ROCE)	14.43%
Revenue Per Employee	481,998
Profits Per Employee	23,353
Employee Count	2,475
Asset Turnover	1.19
Inventory Turnover	2.57

Taxes

In the past 12 months, FRA:PB8 has paid 22.86 million in taxes.

Income Tax	22.86M
Effective Tax Rate	28.34%

Stock Price Statistics

The stock price has increased by +62.50% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+62.50%
50-Day Moving Average	34.92
200-Day Moving Average	25.75
Relative Strength Index (RSI)	50.06
Average Volume (20 Days)	38

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	2.95

Income Statement

In the last 12 months, FRA:PB8 had revenue of EUR 1.19 billion and earned 57.80 million in profits. Earnings per share was 1.42.

Revenue	1.19B
Gross Profit	377.59M
Operating Income	137.17M
Pretax Income	80.66M
Net Income	57.80M
EBITDA	178.09M
EBIT	137.17M
Earnings Per Share (EPS)	1.42

Balance Sheet

The company has 73.21 million in cash and 672.06 million in debt, giving a net cash position of -598.85 million.

Cash & Cash Equivalents	73.21M
Total Debt	672.06M
Net Cash	-598.85M
Net Cash Per Share	n/a
Equity (Book Value)	265.65M
Book Value Per Share	6.55
Working Capital	482.11M

Cash Flow

In the last 12 months, operating cash flow was 65.46 million and capital expenditures -36.24 million, giving a free cash flow of 29.22 million.

Operating Cash Flow	65.46M
Capital Expenditures	-36.24M
Free Cash Flow	29.22M
FCF Per Share	n/a

Margins

Gross margin is 31.65%, with operating and profit margins of 11.50% and 4.85%.

Gross Margin	31.65%
Operating Margin	11.50%
Pretax Margin	6.76%
Profit Margin	4.85%
EBITDA Margin	14.93%
EBIT Margin	11.50%
FCF Margin	2.45%

Dividends & Yields

This stock pays an annual dividend of 0.43, which amounts to a dividend yield of 1.17%.

Dividend Per Share	0.43
Dividend Yield	1.17%
Dividend Growth (YoY)	-4.05%
Years of Dividend Growth	n/a
Payout Ratio	28.68%
Buyback Yield	-0.52%
Shareholder Yield	0.65%
Earnings Yield	4.07%
FCF Yield	2.06%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

FRA:PB8 has an Altman Z-Score of 2.75 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.75
Piotroski F-Score	6